Location History:
- Caburg, AU (1999)
- Northcote, AU (2001)
- Coburg, AU (2002 - 2004)
- Pascoe Vale South, AU (2015)
Company Filing History:
3 out of 122 
1 out of 340 
1 out of 322 
Years Active: 1999-2015
Title: The Innovative Contributions of Stirling John Edwards
Introduction: Stirling John Edwards, an accomplished inventor based in Coburg, Australia, has made significant contributions to the field of immunology through his innovative inventions. With a remarkable portfolio of six patents, Edwards has paved the way for advancements in the development of immune response therapies, particularly targeting papillomavirus.
Latest Patents: Among his most recent patents, Edward's innovative methods stand out. One notable patent, titled "Method of Eliciting or Inducing an Immune Response," describes a technique for administering a composition comprising an antigen and adjuvant via the intra-lung route to elicit or induce an immune response in human or animal subjects. Another significant invention is centered around "Papillomavirus Polyprotein Constructs," which includes a construct made of at least two amino acid sequences fused together. This invention addresses the production of prophylactic or therapeutic compositions aimed at eliciting an immune response against papillomavirus in host animals.
Career Highlights: Throughout his career, Stirling John Edwards has demonstrated his commitment to innovation. His leadership in advancing research on immune response mechanisms has garnered recognition within scientific communities and has potential implications for vaccine development and virology.
Collaborations: Edwards has collaborated with prominent professionals, including Elizabeth Ann Webb and John Cooper Cox, to further enhance the capabilities and applications of his inventions. These collaborations reflect the synergistic approach he adopts in his research endeavors.
Conclusion: Stirling John Edwards stands as a figure of innovation within the realm of immunology. His dedication to developing novel methods and compositions illustrates the transformative potential of scientific research. With a robust patent portfolio and significant collaborations, he continues to impact the future of immune therapies and vaccine advancements.